自我报告便秘的受试者中药使用的流行率和模式:来自跨国消化健康调查的结果
Brian E Lacy1, Régis Delfini2, Bernward Fladung3,4
1Division of Gastroenterology, Mayo Clinic, Jacksonville, FL, USA.
Therapeutic advances in gastroenterology
|March 6, 2024
概括
便秘影响全球许多人,严重影响生活质量. 在自我报告的便秘病例中使用药显示出高满意度,这表明有效的症状管理.
科学领域:
- 胃肠病学 胃肠病学
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 便秘是一种常见的胃肠道 (GI) 疾病,其特点是疲劳,硬便和不频繁的肠道排便.
- 在线调查是收集患者关于便秘的观点的有效工具,包括症状,管理和满意度.
研究的目的:
- 分析患者自我报告的便秘和相关症状的经验.
- 确定与便秘相关的患病率,人口统计数据,对生活质量 (QoL) 的影响和治疗满意度.
主要方法:
- 在七个国家的20099名受访者中进行了一项大规模的在线调查.
- 后期分析侧重于过去六个月和最后一段时间内自我报告的便秘,检查患病率,症状,QoL影响和管理策略.
主要成果:
- 在女性和年轻成年人中,便秘的患病率更高,大多数人报告了同时存在的胃肠道症状.
- 更频繁的便秘发作与对QoL产生更大的负面影响相关 (平均值6.4/10).
- 超过90%的受试者控制了他们的便秘,其中16%使用药,报告80.3%的满意度.
结论:
- 便秘是一种普遍的,慢性疾病,在不同的人群中影响了QoL.
- 自主管理是常见的,使用药的人报告的满意度明显更高,这表明它们的有效性.
相关概念视频
Assessment of the Gastrointestinal System II: Health Perception Pattern
114
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
114
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
208
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
208
Drugs for Treatment of Constipation-Predominant IBS
163
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
163
Assessment of the Gastrointestinal System I: Subjective Data
194
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
194
Drugs Affecting GI Tract Motility: Other Laxatives
216
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
216
Drugs for Treatment of Diarrhea-Predominant IBS
169
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
169


